These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 23201923)

  • 1. Type I interferons in Sjögren's syndrome.
    Yao Y; Liu Z; Jallal B; Shen N; Rönnblom L
    Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Alm GV; Rönnblom L
    Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update.
    Vakaloglou KM; Mavragani CP
    Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications.
    Marketos N; Cinoku I; Rapti A; Mavragani CP
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):185-191. PubMed ID: 31376268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
    Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
    Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Eloranta ML; Ronnblom L
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2054-62. PubMed ID: 22208657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I IFN signature in primary Sjögren's syndrome patients.
    Brkic Z; Versnel MA
    Expert Rev Clin Immunol; 2014 Apr; 10(4):457-67. PubMed ID: 24450331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of Sjögren's syndrome.
    García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Salgado G; Riebeling C; Cervera R
    Arch Med Res; 2006 Nov; 37(8):921-32. PubMed ID: 17045106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells.
    Wildenberg ME; van Helden-Meeuwsen CG; van de Merwe JP; Drexhage HA; Versnel MA
    Eur J Immunol; 2008 Jul; 38(7):2024-33. PubMed ID: 18581327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible etiopathogenic genes of Sjögren's syndrome.
    Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
    Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
    Tomás S; Coll J; Reth P; Corominas JM
    Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the type I interferon pathway in primary Sjogren's syndrome.
    Mavragani CP; Crow MK
    J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
    J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration.
    Molina C; Alliende C; Aguilera S; Kwon YJ; Leyton L; Martínez B; Leyton C; Pérez P; González MJ
    Ann Rheum Dis; 2006 Feb; 65(2):178-83. PubMed ID: 16014676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A diagnostic and etiologic studies of Sjögren's syndrome--II. On the relationship between Sjögren's syndrome and chronic thyroiditis].
    Tanaka O
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Mar; 92(3):374-82. PubMed ID: 2754526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The geoepidemiology of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Autoimmun Rev; 2010 Mar; 9(5):A305-10. PubMed ID: 19903539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.